CytoSorbents Corporation · NASDAQ:CTSO
CytoSorbents — Fact Sheet (2023)
2 slides from CytoSorbents's fact sheet, 2023
Slide 1: Organ Perfusion: First CE certified product for cytokine removal
Demonstrated removal of inflammatory mediators: IL-6, IL-8, TNF-alpha… Preclinical data proves the efficacy in Steen and Belzer solutions First CE certified product for cytokine removal in ex-vivo organ perfusion Contact us today to learn more about the new ECOS-300CY® Therapy Organ Perfusion suppor
Slide 2: Organ transplant trends and introducing ECOS-300CY cytokine adsorption
Organ transplant trends Introducing ECOS-300CY® cytokine adsorption Increasing number of needed organs – decreasing quality of available organs Versatile application in different organs, procedures and platforms Globally, more than 125,000 organs are transplanted every year. While a transplantation